Kelly Hatcher Turner

Kelly Hatcher Turner is a seasoned professional with extensive experience in the biotech and pharmaceutical industries. Currently serving as the Senior Director of Clinical Program Management at United Therapeutics Corporation, Kelly leads clinical program management, contracts, budgets, and clinical supply chain departments while participating in leadership teams for two business units. Previous roles include Director of Lung Biotechnology at United Therapeutics and Head of Global Marketing Strategy for AstraZeneca's Oncology Business Unit. Kelly's career also includes various consulting positions at Booz Allen Hamilton and The Boston Consulting Group. Educational qualifications include an MBA from Harvard Business School and a Certificate in Project Management from Georgetown University.